Rivoglitazone

rivoglitazone · Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Rivoglitazone, covering 2009-02-09 to 2021-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Rivoglitazone in Type 2 Diabetes Mellitus [Phase 3]